Biotech · Private company
SURGE Therapeutics
Track this companyFree. Adds SURGE Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BCSPhase 3 · TNBC - Triple-Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- BCS + SRG-514Phase 3 · TNBC - Triple-Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- STM-416Phase 2 · Non-muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- SRG-514Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- STM-416pPhase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving SurgeryPHASE3 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07723469 · fetched Nov 12, 2026
- Study of STM-416p Administered to Patients Undergoing Radical ProstatectomyPHASE1 · RECRUITING · started May 8, 2025ClinicalTrials.gov NCT06450106 · fetched Nov 12, 2026
- SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer SurgeryPHASE1 · COMPLETED · started Jul 29, 2024ClinicalTrials.gov NCT06300411 · fetched Nov 12, 2026
- A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder CancerPHASE1_PHASE2 · RECRUITING · started Jul 11, 2023ClinicalTrials.gov NCT05710848 · fetched Nov 12, 2026